# Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

> **NCT06745557** · PHASE3 · RECRUITING · sponsor: **CUTISS AG** · enrollment: 70 (estimated)

## Conditions studied

- Burns

## Interventions

- **BIOLOGICAL:** denovoSkin(TM)
- **OTHER:** STSG

## Key facts

- **NCT ID:** NCT06745557
- **Lead sponsor:** CUTISS AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06745557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06745557, "Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06745557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*